{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:45:00Z","timestamp":1791463500642,"version":"4.3.4"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"CSIR-R&D Seed Fund","award":["CSPS24\/RDSF\/IIIM\/IHP24\/03"],"award-info":[{"award-number":["CSPS24\/RDSF\/IIIM\/IHP24\/03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00203-024-04205-y","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T04:15:13Z","timestamp":1735186513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Breaking the resistance: integrative approaches with novel therapeutics against Klebsiella pneumoniae"],"prefix":"10.1007","volume":"207","author":[{"given":"Vimarishi","family":"Koul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwani","family":"Jamwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tashi","family":"Palmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuljit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"4205_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s13204-013-0233-x","volume":"4","author":"Y Abboud","year":"2014","unstructured":"Abboud Y, Saffaj T, Chagraoui A et al (2014) Biosynthesis, characterization and antimicrobial activity of copper oxide nanoparticles (CONPs) produced using brown alga extract (Bifurcaria bifurcata). Appl Nanosci 4:571\u2013576","journal-title":"Appl Nanosci"},{"issue":"6","key":"4205_CR2","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.disamonth.2020.100971","volume":"66","author":"MA Abushaheen","year":"2020","unstructured":"Abushaheen MA, Muzaheed, Fatani AJ et al (2020) Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon 66(6):100971. https:\/\/doi.org\/10.1016\/j.disamonth.2020.100971","journal-title":"Dis Mon"},{"issue":"3","key":"4205_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3934\/microbiol.2020014","volume":"6","author":"O Adesanya","year":"2020","unstructured":"Adesanya O, Oduselu T, Akin-Ajani O, Adewumi OM, Ademowo OG (2020) An exegesis of bacteriophage therapy: an emerging player in the fight against anti-microbial resistance. AIMS Microbiol 6(3):204\u2013230. https:\/\/doi.org\/10.3934\/microbiol.2020014","journal-title":"AIMS Microbiol"},{"issue":"3","key":"4205_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/molecules27030671","volume":"27","author":"AJ Almalki","year":"2022","unstructured":"Almalki AJ, Ibrahim TS, Taher ES et al (2022) Synthesis, antimicrobial, anti-virulence and anticancer evaluation of new 5 (4 H)-oxazolone-based sulfonamides. Molecules 27(3):671","journal-title":"Molecules"},{"key":"4205_CR5","doi-asserted-by":"publisher","first-page":"653562","DOI":"10.3389\/fmicb.2021.653562","volume":"12","author":"A Asghar","year":"2021","unstructured":"Asghar A, Tan Y-C, Shahid M, Yow Y-Y, Lahiri C (2021) Metabolite profiling of Malaysian Gracilaria edulis reveals eplerenone as novel antibacterial compound for drug repurposing against MDR bacteria. Front Microbiol 12:653562","journal-title":"Front Microbiol"},{"issue":"4","key":"4205_CR6","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1007\/s40121-021-00533-4","volume":"10","author":"L Assoni","year":"2021","unstructured":"Assoni L, Girardello R, Converso TR, Darrieux M (2021) Current stage in the development of Klebsiella pneumoniae vaccines. Infect Dis Ther 10(4):2157\u20132175. https:\/\/doi.org\/10.1007\/s40121-021-00533-4","journal-title":"Infect Dis Ther"},{"issue":"3","key":"4205_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20(3):200\u2013216","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"4205_CR8","doi-asserted-by":"publisher","first-page":"e56680","DOI":"10.7759\/cureus.56680","volume":"16","author":"SA B","year":"2024","unstructured":"B SA, Suresh V, Sivaperumal SM (2024) Isolation of secondary metabolites from Marine Actinobacterium of Microbispora sp.T3S11 and their antibacterial activities. Cureus 16(3):e56680. https:\/\/doi.org\/10.7759\/cureus.56680","journal-title":"Cureus"},{"key":"4205_CR9","doi-asserted-by":"publisher","first-page":"897531","DOI":"10.3389\/fcimb.2022.897531","volume":"12","author":"J Bai","year":"2022","unstructured":"Bai J, Zhang F, Liang S et al (2022) Isolation and characterization of vB_kpnM_17\u2009\u2013\u200911, a novel phage efficient against Carbapenem-resistant Klebsiella pneumoniae. Front Cell Infect Microbiol 12:897531. https:\/\/doi.org\/10.3389\/fcimb.2022.897531","journal-title":"Front Cell Infect Microbiol"},{"key":"4205_CR10","first-page":"1732","volume":"12","author":"P Baindara","year":"2023","unstructured":"Baindara P, Mandal SM (2023) Gut-antimicrobial peptides: synergistic co-evolution with antibiotics to Combat Multi-antibiotic Resistance. Antibiot (Basel Switzerland) 12:1732","journal-title":"Antibiot (Basel Switzerland)"},{"issue":"8","key":"4205_CR11","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1099\/mic.0.000316","volume":"162","author":"P Baindara","year":"2016","unstructured":"Baindara P, Singh N, Ranjan M et al (2016) Laterosporulin10: a novel defensin like Class IId bacteriocin from Brevibacillus sp. strain SKDU10 with inhibitory activity against microbial pathogens. Microbiol (Reading) 162(8):1286\u20131299","journal-title":"Microbiol (Reading)"},{"issue":"1","key":"4205_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1515\/opag-2021-0026","volume":"6","author":"SF Bashir","year":"2021","unstructured":"Bashir SF, Kumar G (2021) Preliminary phytochemical screening and in vitro antibacterial activity of Plumbago indica (laal chitrak) root extracts against drug-resistant Escherichia coli and Klebsiella pneumoniae. Open Agric 6(1):435\u2013444","journal-title":"Open Agric"},{"key":"4205_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40824-018-0140-z","volume":"22","author":"R Baskaran","year":"2018","unstructured":"Baskaran R, Lee J, Yang SG (2018) Clinical development of photodynamic agents and therapeutic applications. Biomaterials Res 22:25. https:\/\/doi.org\/10.1186\/s40824-018-0140-z","journal-title":"Biomaterials Res"},{"issue":"10","key":"4205_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/14787210.2018.1522249","volume":"16","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Righi E, Carnelutti A, Graziano E, Russo A (2018) Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control. Expert Rev Anti Infect Ther 16(10):749\u2013761","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4205_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijbiomac.2018.11.101","volume":"124","author":"M Behravan","year":"2019","unstructured":"Behravan M, Panahi AH, Naghizadeh A, Ziaee M, Mahdavi R, Mirzapour A (2019) Facile green synthesis of silver nanoparticles using Berberis vulgaris leaf and root aqueous extract and its antibacterial activity. Int J Biol Macromol 124:148\u2013154","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"4205_CR16","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.bbamem.2018.07.002","volume":"1860","author":"P Bellio","year":"2018","unstructured":"Bellio P, Luzi C, Mancini A et al (2018) Cerium oxide nanoparticles as potential antibiotic adjuvant. Effects of CeO2 nanoparticles on bacterial outer membrane permeability. Biochim Biophys Acta Biomembr 1860(11):2428\u20132435","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"2","key":"4205_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/femsre\/fuy043","volume":"43","author":"JA Bengoechea","year":"2019","unstructured":"Bengoechea JA, Sa Pessoa J (2019) Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS Microbiol Rev 43(2):123\u2013144. https:\/\/doi.org\/10.1093\/femsre\/fuy043","journal-title":"FEMS Microbiol Rev"},{"issue":"5","key":"4205_CR18","first-page":"400","volume":"13","author":"A-S Bereanu","year":"2024","unstructured":"Bereanu A-S, Bereanu R, Mohor C et al (2024) Prevalence of infections and Antimicrobial Resistance of ESKAPE Group Bacteria isolated from patients admitted to the Intensive Care Unit of a County Emergency Hospital in Romania. Antibiot (Basel Switzerland) 13(5):400","journal-title":"Antibiot (Basel Switzerland)"},{"key":"4205_CR19","doi-asserted-by":"crossref","unstructured":"Bhatia P, Sharma A, George AJ et al (2021) Antibacterial activity of medicinal plants against ESKAPE: An update. Heliyon 7(2)","DOI":"10.1016\/j.heliyon.2021.e06310"},{"issue":"24","key":"4205_CR20","doi-asserted-by":"publisher","first-page":"8999","DOI":"10.3390\/molecules27248999","volume":"27","author":"P Bolouri","year":"2022","unstructured":"Bolouri P, Salami R, Kouhi S et al (2022) Applications of essential oils and plant extracts in different industries. Molecules 27(24):8999","journal-title":"Molecules"},{"issue":"1","key":"4205_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher HW, Talbot GH, Bradley JS et al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48(1):1\u201312","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4205_CR22","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/antibiotics12030628","volume":"12","author":"Z Breijyeh","year":"2023","unstructured":"Breijyeh Z, Karaman R (2023) Design and synthesis of novel antimicrobial agents. Antibiotics 12(3):628","journal-title":"Antibiotics"},{"issue":"6","key":"4205_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41429-020-0291-8","volume":"73","author":"MS Butler","year":"2020","unstructured":"Butler MS, Paterson DL (2020) Antibiotics in the clinical pipeline in October 2019. J Antibiot (Tokyo) 73(6):329\u2013364. https:\/\/doi.org\/10.1038\/s41429-020-0291-8","journal-title":"J Antibiot (Tokyo)"},{"key":"4205_CR24","doi-asserted-by":"publisher","first-page":"1153868","DOI":"10.3389\/fcimb.2023.1153868","volume":"13","author":"C Chatupheeraphat","year":"2023","unstructured":"Chatupheeraphat C, Peamchai J, Luk-In S, Eiamphungporn W (2023a) Synergistic effect and antibiofilm activity of the antimicrobial peptide K11 with conventional antibiotics against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae. Front Cell Infect Microbiol 13:1153868","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"4205_CR25","doi-asserted-by":"publisher","first-page":"e0294287","DOI":"10.1371\/journal.pone.0294287","volume":"18","author":"C Chatupheeraphat","year":"2023","unstructured":"Chatupheeraphat C, Peamchai J, Luk-In S, Yainoy S, Eiamphungporn W (2023b) Synergistic effect of two antimicrobial peptides, BP203 and MAP-0403 J-2 with conventional antibiotics against colistin-resistant Escherichia coli and Klebsiella pneumoniae clinical isolates. PLoS ONE 18(11):e0294287","journal-title":"PLoS ONE"},{"key":"4205_CR26","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.2147\/IDR.S462653","volume":"17","author":"X Chen","year":"2024","unstructured":"Chen X, Zhang B, He J et al (2024) Exploration of antimicrobial peptides in the treatment of gentamicin-resistant Klebsiella pneumoniae infection. Infect Drug Resist 17:2591\u20132605","journal-title":"Infect Drug Resist"},{"issue":"5","key":"4205_CR27","first-page":"406","volume":"12","author":"P Cheruvanachari","year":"2022","unstructured":"Cheruvanachari P, Pattnaik S, Mishra M, Pragyandipta P, Naik PK (2022) Terpinen-4-ol, an active constituent of kewda essential oil, mitigates biofilm forming ability of multidrug resistant Staphylococcus aureus and Klebsiella pneumoniae. J Biol Act Prod Nat 12(5):406\u2013420","journal-title":"J Biol Act Prod Nat"},{"key":"4205_CR28","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3389\/fmicb.2019.00953","volume":"10","author":"U Choi","year":"2019","unstructured":"Choi U, Lee CR (2019) Distinct roles of outer membrane porins in antibiotic resistance and membrane Integrity in Escherichia coli. Front Microbiol 10:953. https:\/\/doi.org\/10.3389\/fmicb.2019.00953","journal-title":"Front Microbiol"},{"issue":"1","key":"4205_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","volume":"18","author":"AR Coates","year":"2020","unstructured":"Coates AR, Hu Y, Holt J, Yeh P (2020) Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction. Expert Rev Anti Infect Ther 18(1):5\u201315","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4205_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091332","author":"JH Correia","year":"2021","unstructured":"Correia JH, Rodrigues JA, Pimenta S, Dong T, Yang Z (2021) Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13091332","journal-title":"Pharmaceutics"},{"key":"4205_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13090870","author":"L Cui","year":"2024","unstructured":"Cui L, Watanabe S, Miyanaga K et al (2024) A comprehensive review on phage therapy and phage-based drug development. Antibiot (Basel Switzerland). https:\/\/doi.org\/10.3390\/antibiotics13090870","journal-title":"Antibiot (Basel Switzerland)"},{"issue":"3","key":"4205_CR32","doi-asserted-by":"publisher","first-page":"e00181","DOI":"10.1128\/CMR.00181-19","volume":"33","author":"DM De Oliveira","year":"2020","unstructured":"De Oliveira DM, Forde BM, Kidd TJ et al (2020) Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev 33(3):e00181\u2013e00119","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"4205_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11274-023-03530-6","volume":"39","author":"GHA de Souza","year":"2023","unstructured":"de Souza GHA, Rossato L, de Oliveira AR, Simionatto S (2023) Antimicrobial peptides against polymyxin-resistant Klebsiella pneumoniae: a patent review. World J Microbiol Biotechnol 39(3):86","journal-title":"World J Microbiol Biotechnol"},{"issue":"9","key":"4205_CR34","doi-asserted-by":"publisher","first-page":"ftaa063","DOI":"10.1093\/femspd\/ftaa063","volume":"78","author":"AE DeSarno","year":"2020","unstructured":"DeSarno AE, Parcell BJ, Coote PJ (2020) Repurposing the anti-viral drug zidovudine (AZT) in combination with meropenem as an effective treatment for infections with multi-drug resistant, carbapenemase-producing strains of Klebsiella pneumoniae. Pathog Dis 78(9):ftaa063","journal-title":"Pathog Dis"},{"issue":"2","key":"4205_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/jof8020164","volume":"8","author":"SK Deshmukh","year":"2022","unstructured":"Deshmukh SK, Dufoss\u00e9 L, Chhipa H, Saxena S, Mahajan GB, Gupta MK (2022) Fungal endophytes: a potential source of antibacterial compounds. J Fungi (Basel) 8(2):164","journal-title":"J Fungi (Basel)"},{"key":"4205_CR36","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.3389\/fmicb.2017.02420","volume":"8","author":"RN Dholakiya","year":"2017","unstructured":"Dholakiya RN, Kumar R, Mishra A, Mody KH, Jha B (2017) Antibacterial and antioxidant activities of Novel Actinobacteria strain isolated from Gulf of Khambhat, Gujarat. Front Microbiol 8:2420. https:\/\/doi.org\/10.3389\/fmicb.2017.02420","journal-title":"Front Microbiol"},{"key":"4205_CR37","first-page":"536","volume":"1","author":"A Dowling","year":"2017","unstructured":"Dowling A, O\u2019Dwyer J, Adley C (2017) Antibiotics: Mode Action Mech Resist 1:536\u2013545","journal-title":"Antibiotics: Mode Action Mech Resist"},{"issue":"28","key":"4205_CR38","doi-asserted-by":"publisher","first-page":"17755","DOI":"10.1039\/D2RA03414J","volume":"12","author":"Y Draoui","year":"2022","unstructured":"Draoui Y, Radi S, Tanan A et al (2022) Novel family of bis-pyrazole coordination complexes as potent antibacterial and antifungal agents. RSC Adv 12(28):17755\u201317764","journal-title":"RSC Adv"},{"issue":"2","key":"4205_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/d14020145","volume":"14","author":"LE Du\u021bu","year":"2022","unstructured":"Du'u LE, Popescu ML, Purdel CN et al (2022) Traditional medicinal plants\u2014a possible source of antibacterial activity on respiratory diseases induced by chlamydia pneumoniae, haemophilus influenzae, klebsiella pneumoniae and moraxella catarrhalis. Diversity 14(2):145","journal-title":"Diversity"},{"issue":"1","key":"4205_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12866-023-02854-5","volume":"23","author":"AI El-Sayed","year":"2023","unstructured":"El-Sayed AI, El-Sheekh MM, Makhlof ME (2023) Synergistic antibacterial effects of Ulva lactuca methanolic extract alone and in combination with different antibiotics on multidrug-resistant Klebsiella pneumoniae isolate. BMC Microbiol 23(1):106","journal-title":"BMC Microbiol"},{"issue":"2","key":"4205_CR41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/pharmaceutics12020142","volume":"12","author":"NE Eleraky","year":"2020","unstructured":"Eleraky NE, Allam A, Hassan SB, Omar MM (2020) Nanomedicine fight against antibacterial resistance: an overview of the recent pharmaceutical innovations. Pharmaceutics 12(2):142","journal-title":"Pharmaceutics"},{"issue":"1","key":"4205_CR42","doi-asserted-by":"publisher","first-page":"20088","DOI":"10.1038\/s41598-021-99618-w","volume":"11","author":"SN Esfahani","year":"2021","unstructured":"Esfahani SN, Damavandi MS, Sadeghi P, Nazifi Z, Salari-Jazi A, Massah AR (2021) Synthesis of some novel coumarin isoxazol sulfonamide hybrid compounds, 3D-QSAR studies, and antibacterial evaluation. Sci Rep 11(1):20088","journal-title":"Sci Rep"},{"issue":"3","key":"4205_CR43","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s13738-022-02704-7","volume":"20","author":"HAA Ezelarab","year":"2023","unstructured":"Ezelarab HAA, Hassan HA, Abuo-Rahma GE-DA, Abbas SH (2023) Design, synthesis, and biological investigation of quinoline\/ciprofloxacin hybrids as antimicrobial and anti-proliferative agents. J Iran Chem Soc 20(3):683\u2013700. https:\/\/doi.org\/10.1007\/s13738-022-02704-7","journal-title":"J Iran Chem Soc"},{"key":"4205_CR44","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.2147\/IJN.S198194","volume":"14","author":"U Farooq","year":"2019","unstructured":"Farooq U, Ahmad T, Khan A et al (2019) Rifampicin conjugated silver nanoparticles: a new arena for development of antibiofilm potential against methicillin resistant Staphylococcus aureus and Klebsiella pneumoniae. Int J Nanomed 14:3983\u20133993","journal-title":"Int J Nanomed"},{"issue":"9","key":"4205_CR45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","volume":"14","author":"HC Flemming","year":"2016","unstructured":"Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S (2016) Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14(9):563\u2013575. https:\/\/doi.org\/10.1038\/nrmicro.2016.94","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"4205_CR46","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41570-023-00463-4","volume":"7","author":"A Frei","year":"2023","unstructured":"Frei A, Verderosa AD, Elliott AG, Zuegg J, Blaskovich MA (2023) Metals to combat antimicrobial resistance. Nat Rev Chem 7(3):202\u2013224","journal-title":"Nat Rev Chem"},{"issue":"5","key":"4205_CR47","doi-asserted-by":"publisher","first-page":"e0235822","DOI":"10.1128\/spectrum.02358-22","volume":"10","author":"L Gan","year":"2022","unstructured":"Gan L, Fu H, Tian Z et al (2022) Bacteriophage effectively rescues Pneumonia caused by prevalent multidrug-resistant Klebsiella pneumoniae in the early stage. Microbiol Spectr 10(5):e0235822. https:\/\/doi.org\/10.1128\/spectrum.02358-22","journal-title":"Microbiol Spectr"},{"key":"4205_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bioorg.2018.10.020","volume":"83","author":"W Gao","year":"2019","unstructured":"Gao W, He Y, Li F et al (2019) Antibacterial activity against drug-resistant microbial pathogens of cytochalasan alkaloids from the arthropod-associated fungus Chaetomium Globosum TW1-1. Bioorg Chem 83:98\u2013104","journal-title":"Bioorg Chem"},{"issue":"4","key":"4205_CR49","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/cpt.2197","volume":"109","author":"E Garcia","year":"2021","unstructured":"Garcia E, Diep JK, Sharma R et al (2021) Evaluation strategies for triple-drug combinations against carbapenemase\u2010producing Klebsiella pneumoniae in an in vitro hollow\u2010fiber infection model. Clin Pharmacol Ther 109(4):1074\u20131080","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"4205_CR50","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/idr15040046","volume":"15","author":"M Garvey","year":"2023","unstructured":"Garvey M (2023) Antimicrobial peptides demonstrate activity against resistant bacterial pathogens. Infect Dis Rep 15(4):454\u2013469","journal-title":"Infect Dis Rep"},{"issue":"10","key":"4205_CR51","doi-asserted-by":"publisher","first-page":"8933","DOI":"10.3390\/ijms24108933","volume":"24","author":"MM Ghorab","year":"2023","unstructured":"Ghorab MM, Soliman M, El-Sayyad A, Abdel-Kader GS, El-Batal MS (2023) Synthesis, antimicrobial, and antibiofilm activities of some novel 7-methoxyquinoline derivatives bearing sulfonamide moiety against urinary tract infection-causing pathogenic microbes. Int J Mol Sci 24(10):8933","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4205_CR52","doi-asserted-by":"publisher","first-page":"14429","DOI":"10.1038\/s41598-023-39647-9","volume":"13","author":"M G\u00f3mara-Lomero","year":"2023","unstructured":"G\u00f3mara-Lomero M, L\u00f3pez-Calleja AI, Rezusta A, A\u00ednsa JA, Ram\u00f3n-Garc\u00eda S (2023) In vitro synergy screens of FDA-approved drugs reveal novel zidovudine-and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae. Sci Rep 13(1):14429","journal-title":"Sci Rep"},{"key":"4205_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111889","author":"IA Gonz\u00e1lez","year":"2021","unstructured":"Gonz\u00e1lez IA, Palavecino A, N\u00fa\u00f1ez C et al (2021) Effective treatment against ESBL-producing Klebsiella pneumoniae through synergism of the photodynamic activity of Re (I) compounds with beta-lactams. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13111889","journal-title":"Pharmaceutics"},{"issue":"6","key":"4205_CR54","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1021\/acsinfecdis.0c00001","volume":"6","author":"DA Gray","year":"2020","unstructured":"Gray DA, Wenzel M (2020) Multitarget approaches against multiresistant superbugs. ACS Infect Dis 6(6):1346\u20131365","journal-title":"ACS Infect Dis"},{"issue":"3","key":"4205_CR55","doi-asserted-by":"publisher","first-page":"e31698","DOI":"10.1371\/journal.pone.0031698","volume":"7","author":"J Gu","year":"2012","unstructured":"Gu J, Liu X, Li Y et al (2012) A method for generation phage cocktail with great therapeutic potential. PLoS ONE 7(3):e31698","journal-title":"PLoS ONE"},{"issue":"1","key":"4205_CR56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.diagmicrobio.2013.10.001","volume":"78","author":"BC Haldorsen","year":"2014","unstructured":"Haldorsen BC, Simonsen GS, Sundsfjord A, Samuelsen O (2014) Increased prevalence of aminoglycoside resistance in clinical isolates of Escherichia coli and Klebsiella spp. in Norway is associated with the acquisition of AAC(3)-II and AAC(6\u2019)-Ib. Diagn Microbiol Infect Dis 78(1):66\u201369. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.10.001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4205_CR57","doi-asserted-by":"publisher","first-page":"113922","DOI":"10.1016\/j.addr.2021.113922","volume":"178","author":"S He","year":"2021","unstructured":"He S, Leanse LG, Feng Y (2021) Artificial intelligence and machine learning assisted drug delivery for effective treatment of infectious diseases. Adv Drug Deliv Rev 178:113922. https:\/\/doi.org\/10.1016\/j.addr.2021.113922","journal-title":"Adv Drug Deliv Rev"},{"key":"4205_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020413","author":"HF Hetta","year":"2023","unstructured":"Hetta HF, Ramadan YN, Al-Harbi AI et al (2023) Nanotechnology as a promising approach to Combat multidrug resistant bacteria: a comprehensive review and future perspectives. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11020413","journal-title":"Biomedicines"},{"issue":"1","key":"4205_CR59","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/s2589-7500(23)00221-2","volume":"6","author":"A Howard","year":"2024","unstructured":"Howard A, Aston S, Gerada A et al (2024) Antimicrobial learning systems: an implementation blueprint for artificial intelligence to tackle antimicrobial resistance. Lancet Digit Health 6(1):e79\u2013e86. https:\/\/doi.org\/10.1016\/s2589-7500(23)00221-2","journal-title":"Lancet Digit Health"},{"issue":"9","key":"4205_CR60","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jiac.2018.05.003","volume":"24","author":"W Huang","year":"2018","unstructured":"Huang W, Cheng Y, Li X et al (2018) Neuraminidase inhibitor susceptibility profile of human influenza viruses during the 2016\u20132017 influenza season in Mainland China. J Infect Chemother 24(9):729\u2013733. https:\/\/doi.org\/10.1016\/j.jiac.2018.05.003","journal-title":"J Infect Chemother"},{"issue":"1","key":"4205_CR61","doi-asserted-by":"publisher","first-page":"41999","DOI":"10.1038\/srep41999","volume":"7","author":"S Hubick","year":"2017","unstructured":"Hubick S, Jayaraman A, McKeen A et al (2017) A potent synthetic inorganic antibiotic with activity against drug-resistant pathogens. Sci Rep 7(1):41999","journal-title":"Sci Rep"},{"issue":"23","key":"4205_CR62","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1016\/j.bmcl.2003.07.028","volume":"13","author":"C Hubschwerlen","year":"2003","unstructured":"Hubschwerlen C, Specklin JL, Baeschlin DK et al (2003) Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action. Bioorg Med Chem Lett 13(23):4229\u20134233. https:\/\/doi.org\/10.1016\/j.bmcl.2003.07.028","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"4205_CR63","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1128\/AAC.01123-10","volume":"55","author":"C-H Hung","year":"2011","unstructured":"Hung C-H, Kuo C-F, Wang C-H, Wu C-M, Tsao N (2011) Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice. Antimicrob Agents Chemother 55(4):1358\u20131365","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4205_CR64","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1038\/s41467-023-39029-9","volume":"14","author":"M Ichikawa","year":"2023","unstructured":"Ichikawa M, Nakamoto N, Kredo-Russo S et al (2023) Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis. Nat Commun 14(1):3261. https:\/\/doi.org\/10.1038\/s41467-023-39029-9","journal-title":"Nat Commun"},{"issue":"7","key":"4205_CR65","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.drudis.2022.05.006","volume":"27","author":"J Jampilek","year":"2022","unstructured":"Jampilek J (2022) Drug repurposing to overcome microbial resistance. Drug Discov Today 27(7):2028\u20132041","journal-title":"Drug Discov Today"},{"key":"4205_CR66","doi-asserted-by":"publisher","DOI":"10.1039\/d4md00449c","author":"V Jamwal","year":"2024","unstructured":"Jamwal V, Palmo T, Singh K (2024) Understanding the mechanisms of antimicrobial resistance and potential therapeutic approaches against the Gram-negative pathogen Acinetobacter baumannii. RSC Med Chem. https:\/\/doi.org\/10.1039\/d4md00449c","journal-title":"RSC Med Chem"},{"issue":"2","key":"4205_CR67","doi-asserted-by":"publisher","first-page":"107054","DOI":"10.1016\/j.ijantimicag.2023.107054","volume":"63","author":"E Jeon","year":"2024","unstructured":"Jeon E, Kim MK, Park Y (2024) Efficacy of the bee-venom antimicrobial peptide osmin against sensitive and carbapenem-resistant Klebsiella pneumoniae strains. Int J Antimicrob Agents 63(2):107054","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"4205_CR68","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/jphp.13273","volume":"72","author":"JP Jourdan","year":"2020","unstructured":"Jourdan JP, Bureau R, Rochais C, Dallemagne P (2020) Drug repositioning: a brief overview. J Pharm Pharmacol 72(9):1145\u20131151. https:\/\/doi.org\/10.1111\/jphp.13273","journal-title":"J Pharm Pharmacol"},{"issue":"11","key":"4205_CR69","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1021\/acschembio.5b00523","volume":"10","author":"K Jungmann","year":"2015","unstructured":"Jungmann K, Jansen R, Gerth K et al (2015) Two of a kind\u2013the Biosynthetic pathways of Chlorotonil and Anthracimycin. ACS Chem Biol 10(11):2480\u20132490. https:\/\/doi.org\/10.1021\/acschembio.5b00523","journal-title":"ACS Chem Biol"},{"key":"4205_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041982","author":"A Kaczorowska","year":"2021","unstructured":"Kaczorowska A, Malinga-Drozd M, Ka\u0142as W, Kopaczy\u0144ska M, Wo\u0142owiec S, Borowska K (2021) Biotin-Containing Third Generation Glucoheptoamidated Polyamidoamine Dendrimer for 5-Aminolevulinic Acid Delivery System. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22041982","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4205_CR71","first-page":"8885338","volume":"2020","author":"B Kamurai","year":"2020","unstructured":"Kamurai B, Mombeshora M, Mukanganyama S (2020) Repurposing of drugs for antibacterial activities on selected ESKAPE bacteria Staphylococcus Aureus and Pseudomonas aeruginosa. Int J Microbiol 2020(1):8885338","journal-title":"Int J Microbiol"},{"issue":"2","key":"4205_CR72","first-page":"234","volume":"12","author":"T Karampatakis","year":"2023","unstructured":"Karampatakis T, Tsergouli K, Behzadi P (2023) Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiot (Basel Switzerland) 12(2):234","journal-title":"Antibiot (Basel Switzerland)"},{"issue":"1","key":"4205_CR73","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1038\/s41598-024-53130-z","volume":"14","author":"JN Kaur","year":"2024","unstructured":"Kaur JN, Singh N, Smith NM et al (2024) Next generation antibiotic combinations to combat pan-drug resistant Klebsiella pneumoniae. Sci Rep 14(1):3148","journal-title":"Sci Rep"},{"issue":"12","key":"4205_CR74","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3390\/pathogens11121420","volume":"11","author":"A Koh Jing Jie","year":"2022","unstructured":"Koh Jing Jie A, Hussein M, Rao GG, Li J, Velkov T (2022) Drug repurposing approaches towards defeating multidrug-resistant gram-negative pathogens: novel polymyxin\/non-antibiotic combinations. Pathogens 11(12):1420","journal-title":"Pathogens"},{"issue":"2","key":"4205_CR75","doi-asserted-by":"publisher","first-page":"E110","DOI":"10.1073\/pnas.1512057112","volume":"113","author":"SH Kopf","year":"2016","unstructured":"Kopf SH, Sessions AL, Cowley ES et al (2016) Trace incorporation of heavy water reveals slow and heterogeneous pathogen growth rates in cystic fibrosis sputum. Proc Natl Acad Sci USA 113(2):E110\u2013E116. https:\/\/doi.org\/10.1073\/pnas.1512057112","journal-title":"Proc Natl Acad Sci USA"},{"key":"4205_CR76","doi-asserted-by":"publisher","DOI":"10.1128\/aem.01353-24","author":"X Kou","year":"2024","unstructured":"Kou X, Yang X, Zheng R (2024) Challenges and opportunities of phage therapy for Klebsiella pneumoniae infections. Appl Environ Microbiol. https:\/\/doi.org\/10.1128\/aem.01353-24","journal-title":"Appl Environ Microbiol"},{"key":"4205_CR77","doi-asserted-by":"publisher","first-page":"174436","DOI":"10.1016\/j.ejphar.2021.174436","volume":"910","author":"D Kumari","year":"2021","unstructured":"Kumari D, Perveen S, Sharma R, Singh K (2021) Advancement in leishmaniasis diagnosis and therapeutics: an update. Eur J Pharmacol 910:174436","journal-title":"Eur J Pharmacol"},{"key":"4205_CR78","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","volume":"106","author":"S Kwiatkowski","year":"2018","unstructured":"Kwiatkowski S, Knap B, Przystupski D et al (2018) Photodynamic therapy \u2013 mechanisms, photosensitizers and combinations. Biomed Pharmacother 106:1098\u20131107. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.049","journal-title":"Biomed Pharmacother"},{"key":"4205_CR79","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3389\/fmicb.2020.01669","volume":"11","author":"A Le\u00f3n-Buitimea","year":"2020","unstructured":"Le\u00f3n-Buitimea A, Garza-C\u00e1rdenas CR, Garza-Cervantes JA, Lerma-Escalera JA, Morones-Ram\u00edrez JR (2020) The demand for new antibiotics: antimicrobial peptides, nanoparticles, and combinatorial therapies as future strategies in antibacterial agent design. Front Microbiol 11:1669","journal-title":"Front Microbiol"},{"key":"4205_CR80","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2147\/idr.S453025","volume":"17","author":"Y Li","year":"2024","unstructured":"Li Y, Kumar S, Zhang L (2024a) Mechanisms of antibiotic resistance and developments in therapeutic strategies to Combat Klebsiella pneumoniae infection. Infect Drug Resist 17:1107\u20131119. https:\/\/doi.org\/10.2147\/idr.S453025","journal-title":"Infect Drug Resist"},{"key":"4205_CR81","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2147\/IDR.S453025","volume":"17","author":"Y Li","year":"2024","unstructured":"Li Y, Kumar S, Zhang L (2024b) Mechanisms of antibiotic resistance and developments in therapeutic strategies to Combat Klebsiella pneumoniae infection. Infect Drug Resist 17:1107\u20131119","journal-title":"Infect Drug Resist"},{"issue":"2","key":"4205_CR82","first-page":"134","volume":"27","author":"J-S Lim","year":"2024","unstructured":"Lim J-S, Chai Y-Y, Ser W-X et al (2024) Novel drug candidates against antibiotic-resistant microorganisms: a review. Iran J Basic Med Sci 27(2):134","journal-title":"Iran J Basic Med Sci"},{"issue":"10","key":"4205_CR83","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.7150\/thno.56205","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, Tong Z, Shi J, Li R, Upton M, Wang Z (2021) Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics 11(10):4910","journal-title":"Theranostics"},{"issue":"2","key":"4205_CR84","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/bact.1.2.14590","volume":"1","author":"C Loc-Carrillo","year":"2011","unstructured":"Loc-Carrillo C, Abedon ST (2011) Pros and cons of phage therapy. Bacteriophage 1(2):111\u2013114. https:\/\/doi.org\/10.4161\/bact.1.2.14590","journal-title":"Bacteriophage"},{"key":"4205_CR85","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.actbio.2018.07.038","volume":"78","author":"W Lou","year":"2018","unstructured":"Lou W, Venkataraman S, Zhong G et al (2018) Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection. Acta Biomater 78:78\u201388","journal-title":"Acta Biomater"},{"issue":"01","key":"4205_CR86","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bsheal.2020.08.003","volume":"3","author":"J Lv","year":"2021","unstructured":"Lv J, Deng S, Zhang L (2021) A review of artificial intelligence applications for antimicrobial resistance. Biosaf Health 3(01):22\u201331","journal-title":"Biosaf Health"},{"issue":"5","key":"4205_CR87","first-page":"681","volume":"9","author":"S Maddila","year":"2016","unstructured":"Maddila S, Gorle S, Seshadri N, Lavanya P, Jonnalagadda SB (2016) Synthesis, antibacterial and antifungal activity of novel benzothiazole pyrimidine derivatives. Arzneimittelforschung 9(5):681\u2013687","journal-title":"Arzneimittelforschung"},{"key":"4205_CR88","doi-asserted-by":"publisher","first-page":"131801","DOI":"10.1016\/j.tet.2020.131801","volume":"78","author":"S Majhi","year":"2021","unstructured":"Majhi S, Das D (2021) Chemical derivatization of natural products: Semisynthesis and pharmacological aspects-a decade update. Tetrahedron 78:131801","journal-title":"Tetrahedron"},{"key":"4205_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28062801","author":"SN Mali","year":"2023","unstructured":"Mali SN, Anand A, Zaki MEA et al (2023) Theoretical and anti-Klebsiella pneumoniae evaluations of substituted 2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide and Imidazopyridine Hydrazide Derivatives. Molecules. https:\/\/doi.org\/10.3390\/molecules28062801","journal-title":"Molecules"},{"issue":"4","key":"4205_CR90","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1128\/AAC.02328-15","volume":"60","author":"A Marr","year":"2016","unstructured":"Marr A, Cen S, Hancock R, McMaster W (2016) Identification of synthetic and natural host defense peptides with leishmanicidal activity. Antimicrob Agents Chemother 60(4):2484\u20132491","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4205_CR91","doi-asserted-by":"publisher","first-page":"73","DOI":"10.31183\/imcp.2023.00073","volume":"6","author":"VY Matieta","year":"2023","unstructured":"Matieta VY, Kuete V, (Pallah et al. AT (2023) Anti-Klebsiella and antibiotic-potentiation activities of the methanol extracts of seven Cameroonian dietary plants against multidrug-resistant phenotypes over-expressing AcrAB-TolC efflux pumps. Invest Med Chem Pharmacol 6(1):73","journal-title":"Invest Med Chem Pharmacol"},{"key":"4205_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40064-015-1645-8","volume":"4","author":"AT Mbaveng","year":"2015","unstructured":"Mbaveng AT, Sandjo LP, Tankeo SB et al (2015) Antibacterial activity of nineteen selected natural products against multi-drug resistant gram-negative phenotypes. Springerplus 4:1\u20139","journal-title":"Springerplus"},{"issue":"6","key":"4205_CR93","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3390\/nano11061573","volume":"11","author":"M Moghtaderi","year":"2021","unstructured":"Moghtaderi M, Mirzaie A, Zabet N et al (2021) Enhanced antibacterial activity of Echinacea angustifolia extract against multidrug-resistant Klebsiella pneumoniae through niosome encapsulation. Nanomaterials 11(6):1573","journal-title":"Nanomaterials"},{"issue":"1","key":"4205_CR94","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11030-022-10417-5","volume":"27","author":"S Mohan","year":"2023","unstructured":"Mohan S, Ajay Krishna M, Chandramouli M et al (2023) Antibacterial natural products from microbial and fungal sources: a decade of advances. Mol Divers 27(1):517\u2013541","journal-title":"Mol Divers"},{"issue":"6","key":"4205_CR95","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4236\/abb.2011.26059","volume":"2","author":"BJ Moncla","year":"2011","unstructured":"Moncla BJ, Pryke K, Rohan LC, Graebing PW (2011) Degradation of naturally occurring and engineered antimicrobial peptides by proteases. Adv Biosci Biotechnol 2(6):404\u2013408. https:\/\/doi.org\/10.4236\/abb.2011.26059","journal-title":"Adv Biosci Biotechnol"},{"issue":"3","key":"4205_CR96","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1039\/D4PM00032C","volume":"1","author":"SK Mondal","year":"2024","unstructured":"Mondal SK, Chakraborty S, Manna S, Mandal SM (2024) Antimicrobial nanoparticles: current landscape and future challenges. RSC Pharm 1(3):388\u2013402. https:\/\/doi.org\/10.1039\/D4PM00032C","journal-title":"RSC Pharm"},{"key":"4205_CR97","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR (2019) Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol 10:539","journal-title":"Front Microbiol"},{"issue":"2","key":"4205_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","volume":"4","author":"JM Munita","year":"2016","unstructured":"Munita JM, Arias CA (2016) Mechanisms of antibiotic resistance. Microbiol Spectr 4(2):1\u201324","journal-title":"Microbiol Spectr"},{"issue":"2","key":"4205_CR99","first-page":"200","volume":"11","author":"J Murugaiyan","year":"2022","unstructured":"Murugaiyan J, Kumar PA, Rao GS et al (2022) Progress in alternative strategies to combat antimicrobial resistance: focus on antibiotics. Antibiot (Basel Switzerland) 11(2):200","journal-title":"Antibiot (Basel Switzerland)"},{"issue":"6","key":"4205_CR100","first-page":"129","volume":"19","author":"YF Mustafa","year":"2021","unstructured":"Mustafa YF, Moath KB, Oglah MK, Khalil RR, Mohammed ET (2021) Bioactivity of some natural and semisynthetic coumarin derived compounds. J Sci Res 19(6):129","journal-title":"J Sci Res"},{"key":"4205_CR101","doi-asserted-by":"publisher","first-page":"105201","DOI":"10.1016\/j.ibiod.2021.105201","volume":"159","author":"M Naseer","year":"2021","unstructured":"Naseer M, Ramadan R, Xing J, Samak NA (2021) Facile green synthesis of copper oxide nanoparticles for the eradication of multidrug resistant Klebsiella pneumonia and Helicobacter pylori biofilms. Int Biodeterior Biodegradation 159:105201","journal-title":"Int Biodeterior Biodegradation"},{"issue":"3","key":"4205_CR102","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/femsre\/fux013","volume":"41","author":"S Navon-Venezia","year":"2017","unstructured":"Navon-Venezia S, Kondratyeva K, Carattoli A (2017) Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev 41(3):252\u2013275","journal-title":"FEMS Microbiol Rev"},{"key":"4205_CR103","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1007\/s00253-015-6553-x","volume":"99","author":"TB Ng","year":"2015","unstructured":"Ng TB, Cheung RCF, Wong JH, Bekhit AA, Bekhit AE-D (2015) Antibacterial products of marine organisms. Appl Microbiol Biotechnol 99:4145\u20134173","journal-title":"Appl Microbiol Biotechnol"},{"key":"4205_CR104","doi-asserted-by":"crossref","unstructured":"Niculescu A-G, Grumezescu AM (2021) Photodynamic therapy\u2014an up-to-date review. 11(8):3626","DOI":"10.3390\/app11083626"},{"issue":"9","key":"4205_CR105","doi-asserted-by":"publisher","first-page":"e73867","DOI":"10.1371\/journal.pone.0073867","volume":"8","author":"S Nuding","year":"2013","unstructured":"Nuding S, Gersemann M, Hosaka Y et al (2013) Gastric antimicrobial peptides fail to eradicate Helicobacter pylori infection due to selective induction and resistance. PLoS ONE 8(9):e73867. https:\/\/doi.org\/10.1371\/journal.pone.0073867","journal-title":"PLoS ONE"},{"key":"4205_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13050603","author":"C N\u00fa\u00f1ez","year":"2021","unstructured":"N\u00fa\u00f1ez C, Palavecino A, Gonz\u00e1lez IA, Dreyse P, Palavecino CE (2021) Effective Photodynamic Therapy with Ir(III) for Virulent Clinical Isolates of Extended-Spectrum Beta-Lactamase Klebsiella pneumoniae. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13050603","journal-title":"Pharmaceutics"},{"issue":"1","key":"4205_CR107","doi-asserted-by":"publisher","first-page":"e0244673","DOI":"10.1371\/journal.pone.0244673","volume":"16","author":"JC Ontong","year":"2021","unstructured":"Ontong JC, Ozioma NF, Voravuthikunchai SP, Chusri S (2021) Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates. PLoS ONE 16(1):e0244673. https:\/\/doi.org\/10.1371\/journal.pone.0244673","journal-title":"PLoS ONE"},{"key":"4205_CR108","first-page":"12","volume-title":"WHO Bacterial Priority Pathogens List","author":"WH Organization","year":"2024","unstructured":"Organization WH (2024) WHO Bacterial Priority Pathogens List. World Health Organization, Geneva, pp 12\u201313"},{"issue":"3","key":"4205_CR109","doi-asserted-by":"publisher","first-page":"67","DOI":"10.15407\/biotech12.03.067","volume":"12","author":"O Pallah","year":"2019","unstructured":"Pallah O, Meleshko T, Bati V, Boyko N (2019) Extracts of edible plants stimulators for beneficial microorganisms. Biotechnol Acta 12(3):67\u201374","journal-title":"Biotechnol Acta"},{"issue":"7","key":"4205_CR110","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/jcm8070934","volume":"8","author":"N Petrosillo","year":"2019","unstructured":"Petrosillo N, Taglietti F, Granata G (2019) Treatment options for colistin resistant Klebsiella pneumoniae: present and future. J Clin Med 8(7):934","journal-title":"J Clin Med"},{"key":"4205_CR111","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.jscs.2012.09.004","volume":"20","author":"MS Pillai","year":"2016","unstructured":"Pillai MS, Latha SP (2016) Designing of some novel metallo antibiotics tuning biochemical behaviour towards therapeutics: synthesis, characterisation and pharmacological studies of metal complexes of cefixime. J Saudi Chem Soc 20:S60\u2013S66","journal-title":"J Saudi Chem Soc"},{"key":"4205_CR112","doi-asserted-by":"publisher","first-page":"1460100","DOI":"10.3389\/fddsv.2024.1460100","volume":"4","author":"L Pinzi","year":"2024","unstructured":"Pinzi L, Bisi N, Rastelli G (2024) How drug repurposing can advance drug discovery: challenges and opportunities. Front Drug Discov 4:1460100. https:\/\/doi.org\/10.3389\/fddsv.2024.1460100","journal-title":"Front Drug Discov"},{"issue":"7","key":"4205_CR113","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci F, Pezzotti P, Pantosti A (2015) Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 109(7):309\u2013318","journal-title":"Pathog Glob Health"},{"key":"4205_CR114","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3389\/fphar.2017.00896","volume":"8","author":"JE Pritchard","year":"2017","unstructured":"Pritchard JE, O\u2019Mara TA, Glubb DM (2017) Enhancing the Promise of Drug Repositioning through Genetics. Front Pharmacol 8:896. https:\/\/doi.org\/10.3389\/fphar.2017.00896","journal-title":"Front Pharmacol"},{"key":"4205_CR115","doi-asserted-by":"publisher","first-page":"106103","DOI":"10.1016\/j.ejps.2021.106103","volume":"170","author":"T Pulingam","year":"2022","unstructured":"Pulingam T, Parumasivam T, Gazzali AM et al (2022) Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci 170:106103. https:\/\/doi.org\/10.1016\/j.ejps.2021.106103","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"4205_CR116","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA et al (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18(1):41\u201358","journal-title":"Nat Rev Drug Discov"},{"key":"4205_CR117","first-page":"9","volume":"3","author":"S Quereshi","year":"2010","unstructured":"Quereshi S, Pandey A, Sandhu S (2010) Evaluation of antibacterial activity of different Ganoderma lucidum extracts. People\u2019s J Sci Res 3:9\u201313","journal-title":"People\u2019s J Sci Res"},{"key":"4205_CR118","doi-asserted-by":"publisher","DOI":"10.1099\/acmi.0.000629.v4","author":"EJ Radford","year":"2023","unstructured":"Radford EJ, Whitworth DE, Allison G (2023) Identification of secondary metabolites containing a diketopiperazine core in extracts from myxobacterial strains with growth inhibition activity against a range of prey species. Access Microbiol. https:\/\/doi.org\/10.1099\/acmi.0.000629.v4","journal-title":"Access Microbiol"},{"issue":"3","key":"4205_CR119","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","volume":"4","author":"WC Reygaert","year":"2018","unstructured":"Reygaert WC (2018) An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol 4(3):482\u2013501. https:\/\/doi.org\/10.3934\/microbiol.2018.3.482","journal-title":"AIMS Microbiol"},{"key":"4205_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10091095","author":"M Rima","year":"2021","unstructured":"Rima M, Rima M, Fajloun Z, Sabatier JM, Bechinger B, Naas T (2021) Antimicrobial peptides: a Potent Alternative to Antibiotics. Antibiot (Basel Switzerland). https:\/\/doi.org\/10.3390\/antibiotics10091095","journal-title":"Antibiot (Basel Switzerland)"},{"key":"4205_CR121","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00001-19","author":"TA Russo","year":"2019","unstructured":"Russo TA, Marr CM (2019) Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/cmr.00001-19","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"4205_CR122","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/14787210.2023.2151435","volume":"21","author":"A Russo","year":"2023","unstructured":"Russo A, Fusco P, Morrone HL, Trecarichi EM, Torti C (2023) New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae. Expert Rev Anti Infect Ther 21(1):41\u201355","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"4205_CR123","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jtcme.2019.02.006","volume":"10","author":"SK Sah","year":"2020","unstructured":"Sah SK, Rasool U, Hemalatha S (2020) Andrographis paniculata extract inhibit growth, biofilm formation in multidrug resistant strains of Klebsiella pneumoniae. J Tradit Complement Med 10(6):599\u2013604","journal-title":"J Tradit Complement Med"},{"key":"4205_CR124","doi-asserted-by":"publisher","first-page":"2475067","DOI":"10.1155\/2016\/2475067","volume":"2016","author":"S Santajit","year":"2016","unstructured":"Santajit S, Indrawattana N (2016) Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int 2016:2475067","journal-title":"Biomed Res Int"},{"issue":"1","key":"4205_CR125","first-page":"2716584","volume":"2020","author":"A Sapkota","year":"2020","unstructured":"Sapkota A, Thapa A, Budhathoki A, Sainju M, Shrestha P, Aryal S (2020) Isolation, characterization, and screening of antimicrobial-producing actinomycetes from soil samples. Int J Microbiol 2020(1):2716584","journal-title":"Int J Microbiol"},{"issue":"1","key":"4205_CR126","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12879-021-06253-x","volume":"21","author":"A Savoldi","year":"2021","unstructured":"Savoldi A, Carrara E, Piddock LJV et al (2021) The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies. BMC Infect Dis 21(1):545. https:\/\/doi.org\/10.1186\/s12879-021-06253-x","journal-title":"BMC Infect Dis"},{"issue":"6","key":"4205_CR127","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000464275","volume":"62","author":"E Savov","year":"2017","unstructured":"Savov E, Todorova I, Politi L et al (2017) Colistin Resistance in KPC-2- and SHV-5-Producing Klebsiella pneumoniae clinical isolates in Bulgaria. Chemotherapy 62(6):339\u2013342. https:\/\/doi.org\/10.1159\/000464275","journal-title":"Chemotherapy"},{"issue":"1","key":"4205_CR128","first-page":"135","volume":"4","author":"G Shaik","year":"2014","unstructured":"Shaik G, Sujatha N, Mehar SK (2014) Medicinal plants as source of antibacterial agents to counter Klebsiella pneumoniae. J Appl Pharm Sci 4(1):135\u2013147","journal-title":"J Appl Pharm Sci"},{"issue":"3","key":"4205_CR129","doi-asserted-by":"publisher","first-page":"e04474","DOI":"10.1128\/spectrum.04474-22","volume":"11","author":"P She","year":"2023","unstructured":"She P, Li Y, Li Z et al (2023) Repurposing 9-aminoacridine as an adjuvant enhances the antimicrobial effects of rifampin against multidrug-resistant Klebsiella pneumoniae. Microbiol Spectr 11(3):e04474\u2013e04422","journal-title":"Microbiol Spectr"},{"issue":"10","key":"4205_CR130","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1016\/j.ejmech.2009.05.021","volume":"44","author":"RV Shingalapur","year":"2009","unstructured":"Shingalapur RV, Hosamani KM, Keri RS (2009) Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles. Eur J Med Chem 44(10):4244\u20134248","journal-title":"Eur J Med Chem"},{"key":"4205_CR131","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/978-981-19-7834-0_17","volume-title":"Biomedical Applications and Toxicity of nanomaterials","author":"K Singh","year":"2023","unstructured":"Singh K, Ahlawat S, Kumari D et al (2023) Safety of nanoparticles: emphasis on antimicrobial properties. In: Mohanan PV, Kappalli S (eds) Biomedical Applications and Toxicity of nanomaterials. Springer Nature, Singapore, pp 425\u2013458"},{"key":"4205_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fddsv.2024.1385460","author":"B Singha","year":"2024","unstructured":"Singha B, Singh V, Soni V (2024) Alternative therapeutics to control antimicrobial resistance: a general perspective. Front Drug Discov. https:\/\/doi.org\/10.3389\/fddsv.2024.1385460","journal-title":"Front Drug Discov"},{"issue":"1","key":"4205_CR133","doi-asserted-by":"publisher","first-page":"11390","DOI":"10.1038\/s41598-022-15386-1","volume":"12","author":"S Srisakul","year":"2022","unstructured":"Srisakul S, Wannigama DL, Higgins PG et al (2022) Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin\u2013sulbactam combination therapy. Sci Rep 12(1):11390","journal-title":"Sci Rep"},{"issue":"6","key":"4205_CR134","first-page":"963","volume":"12","author":"D Stojkovi\u0107","year":"2023","unstructured":"Stojkovi\u0107 D, Petrovi\u0107 J, Carevi\u0107 T, Sokovi\u0107 M, Liaras K (2023) Synthetic and semisynthetic compounds as antibacterials Targeting virulence traits in resistant strains: a narrative updated review. Antibiot (Basel Switzerland) 12(6):963","journal-title":"Antibiot (Basel Switzerland)"},{"issue":"6","key":"4205_CR135","doi-asserted-by":"publisher","first-page":"030006052211067","DOI":"10.1177\/03000605221106705","volume":"50","author":"L Sun","year":"2022","unstructured":"Sun L, Sun J, Ding S (2022) In vitro research of combination therapy for multidrug-resistant Klebsiella pneumoniae bloodstream infections. J Int Med Res 50(6):03000605221106705","journal-title":"J Int Med Res"},{"issue":"3","key":"4205_CR136","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1021\/acs.accounts.8b00624","volume":"52","author":"JSM Svendsen","year":"2019","unstructured":"Svendsen JSM, Grant TM, Rennison D, Brimble MA, Svenson J (2019) Very short and stable lactoferricin-derived antimicrobial peptides: Design principles and potential uses. Acc Chem Res 52(3):749\u2013759. https:\/\/doi.org\/10.1021\/acs.accounts.8b00624","journal-title":"Acc Chem Res"},{"issue":"1","key":"4205_CR137","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/ijms13010427","volume":"13","author":"P Szyma\u0144ski","year":"2011","unstructured":"Szyma\u0144ski P, Markowicz M, Mikiciuk-Olasik E (2011) Adaptation of high-throughput screening in drug discovery\u2014toxicological screening tests. Int J Mol Sci 13(1):427\u2013452","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4205_CR138","first-page":"1934578X2312227","volume":"19","author":"M Taibi","year":"2024","unstructured":"Taibi M, Elbouzidi A, Haddou M et al (2024) Chemical profiling, antibacterial efficacy, and synergistic actions of Ptychotis Verticillata Duby essential oil in combination with conventional antibiotics. SAGE open 19(1):1934578X231222785","journal-title":"SAGE open"},{"issue":"9","key":"4205_CR139","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.biochi.2010.02.023","volume":"92","author":"D Takahashi","year":"2010","unstructured":"Takahashi D, Shukla SK, Prakash O, Zhang G (2010) Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity. Biochimie 92(9):1236\u20131241","journal-title":"Biochimie"},{"issue":"17","key":"4205_CR140","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1016\/j.bmc.2006.04.029","volume":"14","author":"VK Tandon","year":"2006","unstructured":"Tandon VK, Yadav DB, Maurya HK, Chaturvedi AK, Shukla PK (2006) Design, synthesis, and biological evaluation of 1, 2, 3-trisubstituted-1, 4-dihydrobenzo [g] quinoxaline-5, 10-diones and related compounds as antifungal and antibacterial agents. Bioorg Med Chem 14(17):6120\u20136126","journal-title":"Bioorg Med Chem"},{"key":"4205_CR141","doi-asserted-by":"publisher","first-page":"11387","DOI":"10.3389\/bjbs.2023.11387","volume":"80","author":"KWK Tang","year":"2023","unstructured":"Tang KWK, Millar BC, Moore JE (2023) Antimicrobial resistance (AMR). Br J Biomed Sci 80:11387. https:\/\/doi.org\/10.3389\/bjbs.2023.11387","journal-title":"Br J Biomed Sci"},{"issue":"23","key":"4205_CR142","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.2174\/0929867326666190125155947","volume":"27","author":"J Tauchen","year":"2020","unstructured":"Tauchen J (2020) Natural products and their (semi-) synthetic forms in the treatment of migraine: history and current status. Curr Med Chem 27(23):3784\u20133808","journal-title":"Curr Med Chem"},{"issue":"5","key":"4205_CR143","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cmi.2022.11.027","volume":"29","author":"U Theuretzbacher","year":"2023","unstructured":"Theuretzbacher U, Baraldi E, Ciabuschi F, Callegari S (2023) Challenges and shortcomings of antibacterial discovery projects. Clin Microbiol Infect 29(5):610\u2013615","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"4205_CR144","doi-asserted-by":"publisher","first-page":"e03522","DOI":"10.1016\/j.heliyon.2020.e03522","volume":"6","author":"MG Tosato","year":"2020","unstructured":"Tosato MG, Schilardi P, Lorenzo de Mele MF, Thomas AH, Lorente C, Mi\u00f1\u00e1n A (2020) Synergistic effect of carboxypterin and methylene blue applied to antimicrobial photodynamic therapy against mature biofilm of Klebsiella pneumoniae. Heliyon 6(3):e03522. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03522","journal-title":"Heliyon"},{"key":"4205_CR145","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fphar.2018.00359","volume":"9","author":"TB Tran","year":"2018","unstructured":"Tran TB, Bergen PJ, Creek DJ, Velkov T, Li J (2018) Synergistic killing of polymyxin B in combination with the antineoplastic drug mitotane against polymyxin-susceptible and-resistant Acinetobacter baumannii: a metabolomic study. Front Pharmacol 9:359","journal-title":"Front Pharmacol"},{"issue":"2","key":"4205_CR146","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/cid\/ciw243","volume":"63","author":"D van Duin","year":"2016","unstructured":"van Duin D, Bonomo RA (2016) Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations. Clin Infect Dis 63(2):234\u2013241","journal-title":"Clin Infect Dis"},{"issue":"9","key":"4205_CR147","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1021\/acsinfecdis.1c00318","volume":"7","author":"E van Groesen","year":"2021","unstructured":"van Groesen E, Slingerland CJ, Innocenti P, Mihajlovic M, Masereeuw R, Martin NI (2021) Vancomyxins: vancomycin-polymyxin nonapeptide conjugates that retain anti-gram-positive activity with enhanced potency against Gram-negative strains. ACS Infect Dis 7(9):2746\u20132754","journal-title":"ACS Infect Dis"},{"issue":"3","key":"4205_CR148","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jacbts.2016.03.002","volume":"1","author":"GA Van Norman","year":"2016","unstructured":"Van Norman GA (2016) Drugs, devices, and the FDA: part 1: an overview of approval processes for drugs. JACC Basic Transl Sci 1(3):170\u2013179. https:\/\/doi.org\/10.1016\/j.jacbts.2016.03.002","journal-title":"JACC Basic Transl Sci"},{"issue":"23\u201324","key":"4205_CR149","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1080\/15287394.2020.1824135","volume":"83","author":"NG Vasconcelos","year":"2020","unstructured":"Vasconcelos NG, Vaz MSM, Radai JAS et al (2020) Antimicrobial activity of plant extracts against carbapenem-producing Klebsiella pneumoniae and in vivo toxicological assessment. J Toxicol Environ Health A 83(23\u201324):719\u2013729","journal-title":"J Toxicol Environ Health A"},{"issue":"3","key":"4205_CR150","doi-asserted-by":"publisher","first-page":"743","DOI":"10.14202\/vetworld.2022.743-749","volume":"15","author":"ME Velazquez-Meza","year":"2022","unstructured":"Velazquez-Meza ME, Galarde-L\u00f3pez M, Carrillo-Quir\u00f3z B, Alpuche-Aranda CM (2022) Antimicrobial resistance: one health approach. Vet World 15(3):743","journal-title":"Vet World"},{"issue":"3","key":"4205_CR151","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41579-019-0294-2","volume":"18","author":"J Vergalli","year":"2020","unstructured":"Vergalli J, Bodrenko IV, Masi M et al (2020) Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria. Nat Rev Microbiol 18(3):164\u2013176. https:\/\/doi.org\/10.1038\/s41579-019-0294-2","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"4205_CR152","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/pharmaceutics14081714","volume":"14","author":"D Vukoja","year":"2022","unstructured":"Vukoja D, Vlaini\u0107 J, Ljoli\u0107 Bili\u0107 V et al (2022) Innovative insights into in vitro activity of colloidal platinum nanoparticles against ESBL-Producing strains of Escherichia coli and Klebsiella pneumoniae. Pharmaceutics 14(8):1714","journal-title":"Pharmaceutics"},{"issue":"4","key":"4205_CR153","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/jam.13533","volume":"123","author":"C Vuotto","year":"2017","unstructured":"Vuotto C, Longo F, Pascolini C et al (2017) Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains. J Appl Microbiol 123(4):1003\u20131018. https:\/\/doi.org\/10.1111\/jam.13533","journal-title":"J Appl Microbiol"},{"key":"4205_CR154","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejmech.2019.01.072","volume":"167","author":"L-L Wang","year":"2019","unstructured":"Wang L-L, Battini N, Bheemanaboina RRY, Zhang S-L, Zhou C-H (2019) Design and synthesis of aminothiazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation. Eur J Med Chem 167:105\u2013123","journal-title":"Eur J Med Chem"},{"key":"4205_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17176278","author":"G Wang","year":"2020","unstructured":"Wang G, Zhao G, Chao X, Xie L, Wang H (2020) The characteristic of virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae. Int J Environ Res Public Health 17(17). https:\/\/doi.org\/10.3390\/ijerph17176278","journal-title":"Int J Environ Res Public Health"},{"key":"4205_CR156","volume-title":"Global technical consultation report on proposed terminology for pathogens that transmit through the air","author":"WHO","year":"2024","unstructured":"WHO (2024) Global technical consultation report on proposed terminology for pathogens that transmit through the air. World Health Organization: Geneva, Switzerland"},{"issue":"1","key":"4205_CR157","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5187\/jast.2022.e92","volume":"65","author":"S-H Woo","year":"2023","unstructured":"Woo S-H, Sung J-M, Park H et al (2023) Inhibitory effect of natural extract mixtures on microbial growth and lipid oxidation of sausages during storage. J Anim Sci Technol 65(1):225","journal-title":"J Anim Sci Technol"},{"issue":"3","key":"4205_CR158","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","volume":"31","author":"RJ Worthington","year":"2013","unstructured":"Worthington RJ, Melander C (2013) Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol 31(3):177\u2013184","journal-title":"Trends Biotechnol"},{"key":"4205_CR159","doi-asserted-by":"publisher","first-page":"100954","DOI":"10.1016\/j.drup.2023.100954","volume":"68","author":"J Xuan","year":"2023","unstructured":"Xuan J, Feng W, Wang J et al (2023) Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resist Updat 68:100954","journal-title":"Drug Resist Updat"},{"issue":"4","key":"4205_CR160","doi-asserted-by":"publisher","first-page":"e0214326","DOI":"10.1371\/journal.pone.0214326","volume":"14","author":"S-K Yang","year":"2019","unstructured":"Yang S-K, Yusoff K, Ajat M et al (2019) Disruption of KPC-producing Klebsiella pneumoniae membrane via induction of oxidative stress by cinnamon bark (Cinnamomum verum J. Presl) essential oil. PLoS ONE 14(4):e0214326","journal-title":"PLoS ONE"},{"issue":"1","key":"4205_CR161","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41598-019-55601-0","volume":"10","author":"S-K Yang","year":"2020","unstructured":"Yang S-K, Yusoff K, Thomas W et al (2020) Lavender essential oil induces oxidative stress which modifies the bacterial membrane permeability of carbapenemase producing Klebsiella pneumoniae. Sci Rep 10(1):819","journal-title":"Sci Rep"},{"issue":"1","key":"4205_CR162","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12934-024-02410-4","volume":"23","author":"J Yang","year":"2024","unstructured":"Yang J, Xu L, Zhou Y et al (2024) Repurposing harmaline as a novel approach to reverse tmexCD1-toprJ1-mediated tigecycline resistance against klebsiella pneumoniae infections. Microb Cell Fact 23(1):152. https:\/\/doi.org\/10.1186\/s12934-024-02410-4","journal-title":"Microb Cell Fact"},{"issue":"2","key":"4205_CR163","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1021\/acsinfecdis.5b00114","volume":"2","author":"V Yarlagadda","year":"2016","unstructured":"Yarlagadda V, Manjunath GB, Sarkar P et al (2016) Glycopeptide antibiotic to overcome the intrinsic resistance of Gram-negative bacteria. ACS Infect Dis 2(2):132\u2013139","journal-title":"ACS Infect Dis"},{"issue":"3","key":"4205_CR164","first-page":"497","volume":"7","author":"M Yass","year":"2023","unstructured":"Yass M, Al-Haddad A, Ali MJM, Jaafar A, Veres M (2023) Effectiveness of green synthesized zinc oxide nanoparticles against extensively drug-resistant Klebsiella pneumoniae. Biomed Biotechnol Res J 7(3):497\u2013503","journal-title":"Biomed Biotechnol Res J"},{"key":"4205_CR165","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jconrel.2016.01.008","volume":"224","author":"H Zazo","year":"2016","unstructured":"Zazo H, Colino CI, Lanao JM (2016) Current applications of nanoparticles in infectious diseases. J Control Release 224:86\u2013102","journal-title":"J Control Release"},{"issue":"3","key":"4205_CR166","first-page":"349","volume":"11","author":"C Zhang","year":"2022","unstructured":"Zhang C, Yang M (2022) Antimicrobial peptides: from design to clinical application. Antibiot (Basel Switzerland) 11(3):349","journal-title":"Antibiot (Basel Switzerland)"},{"issue":"7","key":"4205_CR167","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1093\/jac\/dkac128","volume":"77","author":"X Zhang","year":"2022","unstructured":"Zhang X, Shi S, Yao Z et al (2022) Antimicrobial peptide WAM-1: a promising antibacterial and anti-inflammatory drug against carbapenem-resistant Klebsiella pneumoniae. J Antimicrob Chemother 77(7):1903\u20131911","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"4205_CR168","doi-asserted-by":"publisher","first-page":"e0060724","DOI":"10.1128\/msystems.00607-24","volume":"9","author":"M Zhao","year":"2024","unstructured":"Zhao M, Li H, Gan D, Wang M, Deng H, Yang QE (2024) Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic Klebsiella pneumoniae. mSystems 9(9):e0060724. https:\/\/doi.org\/10.1128\/msystems.00607-24","journal-title":"mSystems"},{"key":"4205_CR169","doi-asserted-by":"publisher","first-page":"838790","DOI":"10.3389\/fmicb.2022.838790","volume":"13","author":"M Zhou","year":"2022","unstructured":"Zhou M, Wang L, Wang Z et al (2022) Molecular characterization of penicillin-binding Protein2x, 2b and 1a of Streptococcus pneumoniae causing Invasive Pneumococcal diseases in China: a Multicenter Study. Front Microbiol 13:838790. https:\/\/doi.org\/10.3389\/fmicb.2022.838790","journal-title":"Front Microbiol"},{"key":"4205_CR170","doi-asserted-by":"publisher","first-page":"642484","DOI":"10.3389\/fmicb.2021.642484","volume":"12","author":"J Zhu","year":"2021","unstructured":"Zhu J, Wang T, Chen L, Du H (2021a) Virulence factors in Hypervirulent Klebsiella pneumoniae. Front Microbiol 12:642484. https:\/\/doi.org\/10.3389\/fmicb.2021.642484","journal-title":"Front Microbiol"},{"issue":"1","key":"4205_CR171","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.14649","volume":"1496","author":"M Zhu","year":"2021","unstructured":"Zhu M, Tse MW, Weller J, Chen J, Blainey PC (2021b) The future of antibiotics begins with discovering new combinations. Ann N Y Acad Sci 1496(1):82\u201396. https:\/\/doi.org\/10.1111\/nyas.14649","journal-title":"Ann N Y Acad Sci"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-024-04205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-024-04205-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-024-04205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T03:33:21Z","timestamp":1737689601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-024-04205-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":171,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4205"],"URL":"https:\/\/doi.org\/10.1007\/s00203-024-04205-y","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that this article has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"18"}}